期刊
BIOANALYSIS
卷 8, 期 19, 页码 1997-2005出版社
FUTURE SCI LTD
DOI: 10.4155/bio-2016-0086
关键词
endogenous biomarker; fit-for-purpose validation; LC-MS/MS; surrogate analyte
资金
- Bristol-Myers Squibb Company
Background: Creatinine is an endogenous compound generated from creatine by normal muscular metabolism. It is an important indicator of renal function and the serum level is routinely monitored in clinical labs. Results & methodology: Surrogate analyte (d3-creatinine) was used for calibration standard and quality control preparation and the relative instrument response ratio between creatinine and d3-creatinine was used to calculate the endogenous creatinine concentrations. Conclusion: A fit-for-purpose strategy of using a surrogate analyte and authentic matrix was adopted for this validation. The assay was the first human plasma assay using such strategy and was successfully applied to a clinical study to confirm a transient elevation of creatinine observed using an existing clinical assay.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据